Effects of Cardiac Overexpression of the Angiotensin II Type 2 Receptor on Remodeling and Dysfunction in Mice Post–Myocardial Infarction
Authors:
- 1 June 2014
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 63 (6) , 1251-1259
Abstract
The activation of angiotensin II type 2 receptor (AT2R) has been considered cardioprotective. However, there are controversial findings regarding the role of overexpressing AT2R in the heart. Using transgenic mice with different levels of AT2R gene overexpression in the heart (1, 4, or 9 copies of the AT2R transgene: Tg1, Tg4, or Tg9), we studied the effect of AT2R overexpression on left ventricular remodeling and dysfunction post–myocardial infarction (MI). Tg1, Tg4, Tg9, and their wild-type littermates were divided into (1) sham MI, (2) MI plus vehicle, and (3) MI plus AT2R antagonist. Treatments were started 4 weeks after MI and continued for 8 weeks. AT2R protein and mRNA expression in the heart was significantly increased in transgenic mice, and the increase positively correlated with copies of the transgene. AT1R protein and mRNA expression remained unchanged in Tg1and Tg4but slightly increased in Tg9mice. Systolic blood pressure and cardiac phenotypes did not differ among strains under basal conditions. MI caused myocardial hypertrophy, interstitial fibrosis, ventricular dilatation, and dysfunction associated with increased protein expression of Nox2 and transforming growth factor β1. These pathological responses were diminished in Tg1and Tg4mice. Moreover, the protective effects of AT2R were abolished by AT2R antagonist and also absent in Tg9mice. We thus conclude that whether overexpression of AT2R is beneficial or detrimental to the heart is largely dependent on expression levels and possibly via regulations of Nox2 and transforming growth factor β1signaling pathways.Keywords
This publication has 32 references indexed in Scilit:
- Angiotensin II-induced vasodilation via type 2 receptor: Role of bradykinin and nitric oxideInternational Immunopharmacology, 2008
- Role of cardiac overexpression of ANG II in the regulation of cardiac function and remodeling postmyocardial infarctionAmerican Journal of Physiology-Heart and Circulatory Physiology, 2007
- AT2 receptor mediates the cardioprotective effects of AT1 receptor antagonist in post-myocardial infarction remodelingLife Sciences, 2006
- Role of transforming growth factor-β in the progression of heart failureCellular and Molecular Life Sciences, 2006
- The Angiotensin II Type 2 Receptor Causes Constitutive Growth of Cardiomyocytes and Does Not Antagonize Angiotensin II Type 1 Receptor–Mediated HypertrophyHypertension, 2005
- Deletion of Angiotensin II Type 2 Receptor Exaggerated Atherosclerosis in Apolipoprotein E–Null MiceCirculation, 2005
- Angiotensin II AT2 receptor localization in cardiovascular tissues by its antibody developed in AT2 gene-deleted miceRegulatory Peptides, 2005
- Chronic ventricular myocyte-specific overexpression of angiotensin II type 2 receptor results in intrinsic myocyte contractile dysfunctionAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects.Journal of Clinical Investigation, 1998
- Differential Distribution of Angiotensin AT2 Receptors in the Normal and Failing Human HeartThe Journal of Pharmacology and Experimental Therapeutics, 1998